# George E. Georges

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/george-e-georges/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7,245 |
| Field | Hematopoietic Stem Cell Transplantation |
| h-index | 37 |
| i10-index | 73 |
| OpenAlex ID | https://openalex.org/A5013130893 |
| ORCID iD | 0000-0002-0625-0858 |
| Works | 180 |

## Researcher papers

- [Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects](https://scholariq.org/papers/hematopoietic-cell-transplantation-in-older-patients-with-hematologic/)
- [Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma](https://scholariq.org/papers/myeloablative-autologous-stem-cell-transplantation-for-severe-scleroderma/)
- [Animal Models for Medical Countermeasures to Radiation Exposure](https://scholariq.org/papers/animal-models-for-medical-countermeasures-to-radiation-exposure/)
- [Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies](https://scholariq.org/papers/long-term-outcomes-among-older-patients-following-nonmyeloablative-conditioning/)
- [Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis](https://scholariq.org/papers/long-term-outcomes-after-autologous-hematopoietic-stem-cell-transplantation-for/)
- [Allogeneic hematopoietic stem cell transplantation for myelofibrosis](https://scholariq.org/papers/allogeneic-hematopoietic-stem-cell-transplantation-for-myelofibrosis/)
- [CD34 cell dose in granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen–identical sibling transplantation](https://scholariq.org/papers/cd34-cell-dose-in-granulocyte-colony-stimulating-factor-mobilized-peripheral/)
- [High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis](https://scholariq.org/papers/high-dose-immunosuppressive-therapy-and-autologous-peripheral-blood-stem-cell/)
- [Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation](https://scholariq.org/papers/graft-versus-host-disease-and-graft-versus-tumor-effects-after-allogeneic/)
- [Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential Thrombocythemia](https://scholariq.org/papers/hematopoietic-cell-transplantation-as-curative-therapy-for-idiopathic/)
- [Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/targeting-b-cells-in-immune-mediated-kidney-diseases-conclusions-from-a-kidney/)

## Researcher topics

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Mesenchymal stem cell research](https://scholariq.org/topics/mesenchymal-stem-cell-research/)
- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research/)
- [Polyomavirus and related diseases](https://scholariq.org/topics/polyomavirus-and-related-diseases/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.